Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep478 | Thyroid | ECE2020

Recurrent subacute thyroiditis case of an elderly patient

Hepsen Sema , Ucan Bekir , Akhanli Pinar , Kizilgul Muhammed , Cakal Erman

Introduction: Subacute thyroiditis (SAT) is the inflammatory disease of thyroid gland, which commonly affects middle-aged females. SAT is rarely seen in extreme age groups. Herein, we reported an 82-year-old patient presenting recurrent SAT.Case report: An 82-year-old female patient presented fever, neck pain, weakness, and dizziness. She had hypertension and peripheral vascular disease. She had a 2-week of symptom history and admitted to emergency servi...

ea0049ep1097 | Female Reproduction | ECE2017

Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome

Karakose Mellia , Hepsen Sema , Cakal Erman , Arslan Muyesser , Tutal Esra , Akin Safak , Unsal Ilknur , Ozbek Mustafa

Background and aim: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorder in women with reproductive age. Nodular goiter and autoimmune thyroid disease (AITD) are frequently seen endocrinological abnormalities. The aim of this study was to identify the prevalence of AITD and nodular goiter in PCOS patients and investigate whether PCOS related hormones and metabolic factors affect these thyroid disorders.Methods: Ninety-seven with ...

ea0070aep188 | Bone and Calcium | ECE2020

Hypercalcemia and primary hyperparathyroidism case progressing during the treatment of dapagliflozin

Akhanli Pinar , Hepsen Sema , Uçan Bekir , Saylam Güleser , Çakal Erman

Introduction: Hypercalcemia associated with the use of a SGLT-2 inhibitor is a very rare adverse effect. Herein we reported a case of apparent primary hyperparathyroidism that occurred while applying the treatment of dapagliflozin in a patient with asymptomatic primary hyperparathyroidism.Case report: A 49-year-old male patient with 5 years of diabetes mellitus history admitted for his routine control and Hba1c level was observed 7.9%. Dapagliflozin (1 &...

ea0070aep770 | Pituitary and Neuroendocrinology | ECE2020

Massive pulmonary embolism in a newly diagnosed acromegaly patient

Hepsen Sema , Ucan Bekir , Akhanli Pinar , Ozturk Unsal Ilknur , Cakal Erman

Introduction: Acromegaly is caused by growth hormone (GH) and insulin-like growth factor (IGF-1) excess and leads to various comorbidities. However, the association between acromegaly and thromboembolic diseases is unclear. Herein, we present a newly diagnosed acromegaly patient with massive pulmonary embolism.Case report: A 61-year-old female was hospitalized with acromegaly pre-diagnosis. She complained about extensive arthralgia and snoring. She had h...

ea0070ep548 | Hot topics (including COVID-19) | ECE2020

Teriparatide treatment in a patient with resistance hypoparathyroidism

Erkam Sencar Muhammed , Calapkulu Murat , Ozturk Unsal İlknur , Hepsen Sema , Ozbek Mustafa , Cakal Erman

Background: Hypoparathyroidism is an uncommon disorder of calcium metabolism characterized by hypocalcemia, hyperphosphatemia, and reduced level of parathyroid hormone (PTH). The most common cause of hypoparathyroidism is accidental damage to the parathyroid glands during thyroid surgery. There are no formal guidelines for hypoparathyroidism management. The main goal of treatment is to improve the symptoms of hypocalcemia, to keep the serum calcium within the low normal range,...

ea0073aep816 | Late Breaking | ECE2021

24-week impact of dapagliflozin treatment on body weight, body composition, and cardiac risk indicators of patients with type-2 diabetes mellitus

Akhanli Pinar , Hepsen Sema , Emre Arslan Ismail , Duger Hakan , Bostan Hayri , Kizilgul Muhammed , Ucan Bekir , Cakal Erman

AimsWe aimed to reveal the impacts of dapagliflozin, a sodium glucose transporter inhibitor (SGLT2i), on the body weight and body composition, cardiovascular risk indexes, and carotis intima-media thickness (CIMT).MethodsBody weights, body compositions measured by means of bioelectrical impedance, and CIMT in the baseline, the 12th, and the 24th week of 42 patients with type-2 diabetes mellitus receiving SGLT...

ea0073aep873 | Late Breaking | ECE2021

Changes in thyroid hormones and free triiodothyronine-to-free thyroxine ratio in euthyroid patients with obesity in terms of different glucose metabolism statuses

Hepsen Sema , Akhanli Pinar , Erkam Sencar Muhammed , Duger Hakan , Bostan Hayri , Kizilgul Muhammed , Emre Arslan Ismail , Cakal Erman

PurposeThyroid hormones are known to have an essential role in the regulation of energy homeostasis and glucose metabolism. Considering to literature data, variations of thyroid hormones within normal ranges change in obesity and type 2 diabetes mellitus (T2DM) in opposite ways. This study aims to evaluate thyroid hormone levels and fT3/fT4 ratio in different glucose metabolism statuses of euthyroid patients with obesity.Methods</p...

ea0090p441 | Pituitary and Neuroendocrinology | ECE2023

Prevalence and related risk factors of simple renal cysts and nephrolithiasis in acromegaly

Bostan Hayri , Kizilgul Muhammed , Calapkulu Murat , Kozan Kalkisim Hatice , Betul Gulden Topcu Fatma , Gul Umran , Duger Hakan , Hepsen Sema , Ucan Bekir , Cakal Erman

Background: The growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis has effects on renal growth and electrolyte regulation. However, data on adverse renal comorbidities such as renal cysts and stones in acromegaly is scarce. The current study aimed to investigate the prevalence of radiologically detectable renal comorbidities and possible related factors in the acromegaly population.Methods: A total of 125 patients with acromegaly (46.4&pm;11.6...